Rosiglitazone and cardiovascular disease: a cardiologist's perspective.
Marx
Nikolaus
N
Department of Internal Medicine II, University of Ulm, Robert-Koch Strasse 8, D-89081 Ulm, Germany. nikolaus.marx@uniklinik-ulm.de
D002986:Clinical Trials as Topic / Q000379:methods; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000139:chemically induced*; D012107:Research Design; D018570:Risk Assessment; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone